blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4299591

EP4299591 - PREPARATION OF SIGLEC-15 BINDING PROTEIN AND USE THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  01.12.2023
Database last updated on 19.07.2024
FormerThe international publication has been made
Status updated on  03.09.2022
Most recent event   Tooltip27.04.2024Change: Validation statespublished on 29.05.2024  [2024/22]
27.04.2024Change - extension statespublished on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Shanghai Jemincare Pharmaceuticals Co., Ltd.
1st Floor, Block 1
No. 1118 Halei Road
Pilot Free Trade Zone
Pudong New Area, Shanghai 201203 / CN
For all designated states
Jiangxi Jemincare Group Co., Ltd.
Block 14, Zhongxing Nanchang Software Park
Industrial Park
No.688 Aixihu North Road
Nanchang Hi-Tech Industrial Development Zone
Nanchang, Jiangxi 330096 / CN
[2024/01]
Inventor(s)01 / YANG, Xinxiu
Shanghai 201203 / CN
02 / GU, Chunyin
Shanghai 201203 / CN
03 / WANG, Zongda
Shanghai 201203 / CN
04 / CAO, Xiaodan
Shanghai 201203 / CN
05 / LIU, Xiaowu
Shanghai 201203 / CN
06 / LIU, Peipei
Shanghai 201203 / CN
07 / YANG, Lu
Shanghai 201203 / CN
08 / DENG, Sujun
Shanghai 201203 / CN
09 / PAN, Zhongzong
Shanghai 201203 / CN
10 / WANG, Xueping
Shanghai 201203 / CN
 [2024/01]
Representative(s)Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
[N/P]
Former [2024/01]Sagittarius IP
Marlow International
Parkway
Marlow, SL7 1YL / GB
Application number, filing date22758847.222.02.2022
[2024/01]
WO2022CN77193
Priority number, dateCN20211020206523.02.2021         Original published format: CN202110202065
[2024/01]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022179483
Date:01.09.2022
Language:ZH
[2022/35]
Type: A1 Application with search report 
No.:EP4299591
Date:03.01.2024
Language:EN
[2024/01]
Search report(s)International search report - published on:CN01.09.2022
ClassificationIPC:C07K16/28, C12N15/13, A61K39/395, A61P35/00
[2024/01]
CPC:
A61P35/00 (EP,KR); C07K16/2803 (EP,KR,US); A61P37/06 (US);
C12N15/63 (US); G01N33/6854 (US); A61K2039/505 (EP,KR);
C07K2317/14 (US); C07K2317/56 (KR); C07K2317/565 (KR,US);
C07K2317/567 (US); C07K2317/622 (EP,KR); C07K2317/73 (KR,US);
C07K2317/76 (EP); C07K2317/92 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/01]
TitleGerman:HERSTELLUNG VON SIGLEC-15-BINDUNGSPROTEIN UND VERWENDUNG DAVON[2024/01]
English:PREPARATION OF SIGLEC-15 BINDING PROTEIN AND USE THEREOF[2024/01]
French:PRÉPARATION DE PROTÉINE DE LIAISON DE SIGLEC-15 ET SON UTILISATION[2024/01]
Entry into regional phase14.09.2023Translation filed 
14.09.2023National basic fee paid 
14.09.2023Search fee paid 
14.09.2023Designation fee(s) paid 
14.09.2023Examination fee paid 
Examination procedure14.09.2023Examination requested  [2024/01]
08.04.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
14.09.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2011041894  (ALETHIA BIOTHERAPEUTICS INC [CA], et al) [A] 1-122 * entire document *;
 [A]WO2013147213  (DAIICHI SANKYO CO LTD [JP]) [A] 1-122 * entire document *;
 [A]CN110386982  (GUANGDONG 999 BRAIN HOSPITAL, et al) [A] 1-122 * entire document *;
 [A]CN111378043  (UNIV NANJING MEDICAL) [A] 1-122 * entire document *;
 [A]CN111875708  (ZHEJIANG COMPVSS BIOTECHNOLOGY CO LTD) [A] 1-122 * entire document *;
 [A]  - Sasa Chu, Na You, Maorong Wang, "Progress on Siglecs in Sepsis", Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), (20181015), vol. 12, no. 5, doi:10.3877/cma.j.issn.1674-1358, pages 417 - 421, XP055962545 [A] 1-122 * pp. 417-421 *

DOI:   http://dx.doi.org/10.3877/cma.j.issn.1674-1358
 [A]  - Zheng, Yu, "Research Progress of The Relationship Between Siglec Families and Atherosclerosis Associated Immune Cells", Nucleic Acids Research, Oxford University Press, GB, GB , (20171231), vol. 25, no. 7, doi:10.1093/nar/gkv1239, ISSN 0305-1048, XP055962547 [A] 1-122 * pp. 732-736 *

DOI:   http://dx.doi.org/10.1093/nar/gkv1239
 [A]  - Sato Dai; Takahata Masahiko; Ota Masahiro; Fukuda Chie; Hasegawa Tomoka; Yamamoto Tomomaya; Amizuka Norio; Tsuda Eisuke; Okada Akiko; Hiruma Yoshiharu; Fujita Ryo; Iwasaki Norimasa, "Siglec-15-targeting therapy protects against glucocorticoid-induced osteoporosis of growing skeleton in juvenile rats", BONE, PERGAMON PRESS., OXFORD, GB, GB , (20200323), vol. 135, doi:10.1016/j.bone.2020.115331, ISSN 8756-3282, XP086148956 [A] 1-122 * article 115331, pp. 1-10 *

DOI:   http://dx.doi.org/10.1016/j.bone.2020.115331
 [A]  - Wang Jun; Sun Jingwei; Liu Linda N.; Flies Dallas B.; Nie Xinxin; Toki Maria; Zhang Jianping; Song Chang; Zarr Melissa; Zhou Xu; Han Xue; Archer Kristina A.; O’Neill Thomas; Herbst Roy S.; Boto Agedi N.; Sanmamed Miguel F.; Langermann Solomon; Rimm David L.; Chen Lieping, "Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy", Nature Medicine, Nature Publishing Group US, New York, New York, (20190304), vol. 25, no. 4, doi:10.1038/s41591-019-0374-x, ISSN 1078-8956, pages 656 - 666, XP036749914 [A] 1-122 * pp. 656-666 *

DOI:   http://dx.doi.org/10.1038/s41591-019-0374-x
by applicant   - "Uniprot", Database accession no. P10966
    - LEFRANC et al., Nucleic Acids Res., (19990000), vol. 27, pages 209 - 212
    - RUIZ et al., Nucleic Acids Res., (20000000), vol. 28, pages 219 - 221
    - LEFRANC et al., Nucleic Acids Res., (20010000), vol. 29, pages 207 - 209
    - LEFRANC et al., Nucleic Acids Res., (20030000), vol. 31, pages 307 - 310
    - LEFRANC et al., DevComp Immunol, (20050000), vol. 29, pages 185 - 203
    - KABAT EAWU TT, Ann NY AcadSci, (19710000), vol. 190, pages 382 - 391
    - WARD et al., Nature, (19891000), vol. 341, no. 6242, pages 544 - 6
    - HOLT et al., Trends Biotechnol., (20030000), vol. 21, no. 11, pages 484 - 490
    - VANLANDSCHOOT P. et al., Antiviral Research, (20110000), vol. 92, pages 389 - 407
    - W. R. PEARSOND. J. LIPMAN, "Improved Tools for Biological Sequence Comparison", Proc. Natl. Acad. Sci., (19880000), vol. 85, pages 2444 - 2448
    - D. J. LIPMANW. R. PEARSON, "Rapid and Sensitive Protein Similarity Searches", Science, (19890000), vol. 227, pages 1435 - 1441
    - S. ALTSCHULW. GISHW. MILLERE. W. MYERSD. LIPMAN, "A Basic Local Alignment Search Tool", J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
    - BRUMMELL et al., Biochem, (19930000), vol. 32, pages 1180 - 8
    - DE WILDT et al., Prot. Eng., (19970000), vol. 10, pages 835 - 41
    - KOMISSAROV et al., J. Biol. Chem., (19970000), vol. 272, pages 26864 - 26870
    - HALL et al., J. Immunol., (19920000), vol. 149, pages 1605 - 12
    - KELLEYO'CONNELL, Biochem., (19930000), vol. 32, pages 6862 - 35
    - ADIB-CONQUY et al., Int. Immunol., (19980000), vol. 10, pages 341 - 6
    - BEERS et al., Clin. Can. Res., (20000000), vol. 6, pages 2835 - 43
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.